Matinas BioPharma
MTNB
MTNB
42 hedge funds and large institutions have $6.91M invested in Matinas BioPharma in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-9
Holders Change %
-17.65%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$152K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$35.1K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$18.5K |
| 4 |
SW
Simplicity Wealth
Summit,
New Jersey
|
+$16.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12.2K |
Top Sellers
| 1 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$68.7K |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$56.2K |
| 3 |
VF
Virtu Financial
New York
|
-$35K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$33.9K |
| 5 |
Bank of New York Mellon
New York
|
-$19K |